Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
290.5500
-5.55
(
-1.87
%)
NSE
Mar 16, 2026
15:30 PM
New 52W Low in past week
Volume:
604.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
29 Feb 2024
290.55
-1.87%
SUVEN PHARMACEUTICALS LIMITED
Sell:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 571
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences.. has an
average target
of 527.00 from 2 brokers.
More from Cohance Lifesciences Ltd.
Recommended
Market trades higher, Bandhan Bank's promoter reportedly plans a stake sale
Trendlyne Marketwatch |
16 Mar 2026, 03:25PM
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026
India is (finally) opening up to the world
The Baseline |
13 Mar 2026